https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/European-Medicines-Agency-Accepts-Biogen-s-Aducanumab-Marketing-Authorization-Application-for-Alzh-31650893/?utm_source=telegram&utm_medium=social&utm_campaign=share